These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 35343231)

  • 1. Nanomaterials: The New Antimicrobial Magic Bullet.
    Ndayishimiye J; Kumeria T; Popat A; Falconer JR; Blaskovich MAT
    ACS Infect Dis; 2022 Apr; 8(4):693-712. PubMed ID: 35343231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
    Makabenta JMV; Nabawy A; Li CH; Schmidt-Malan S; Patel R; Rotello VM
    Nat Rev Microbiol; 2021 Jan; 19(1):23-36. PubMed ID: 32814862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.
    Karnwal A; Kumar G; Pant G; Hossain K; Ahmad A; Alshammari MB
    ACS Omega; 2023 Apr; 8(15):13492-13508. PubMed ID: 37091369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
    Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
    Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterial-based treatments for medical device-associated infections.
    Tran N; Tran PA
    Chemphyschem; 2012 Jul; 13(10):2481-94. PubMed ID: 22517627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Resistance and Inorganic Nanoparticles.
    Balderrama-González AS; Piñón-Castillo HA; Ramírez-Valdespino CA; Landeros-Martínez LL; Orrantia-Borunda E; Esparza-Ponce HE
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics.
    Santos RS; Figueiredo C; Azevedo NF; Braeckmans K; De Smedt SC
    Adv Drug Deliv Rev; 2018; 136-137():28-48. PubMed ID: 29248479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact and safety of encapsulated nanomaterials as a new alternative against carbapenem resistant bacteria. a systematic review.
    Abdallah OM; Shebl HR; Abdelsalam E; Mehrez SI
    World J Microbiol Biotechnol; 2024 Jan; 40(2):72. PubMed ID: 38233674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
    Adeniji OO; Nontongana N; Okoh JC; Okoh AI
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-vehicles give new lease of life to existing antimicrobials.
    Mela I; Kaminski CF
    Emerg Top Life Sci; 2020 Dec; 4(6):555-566. PubMed ID: 33258900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance and nanotechnology: A narrative review.
    Zhu X; Tang Q; Zhou X; Momeni MR
    Microb Pathog; 2024 Aug; 193():106741. PubMed ID: 38871198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent strategies for inhibiting multidrug-resistant and β-lactamase producing bacteria: A review.
    Fatima H; Goel N; Sinha R; Khare SK
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111901. PubMed ID: 34116398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.